Agonist comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-09-20. Where a claim depends on a specific study, the study is described rather than over-claimed.
Outside the approved product, bremelanotide circulates as a research chemical sold by peptide vendors, often labelled PT-141. Such material is not manufactured under pharmaceutical quality standards, and independent testing has repeatedly found content that differs from the label. Analytical certificates supplied with a purchase are not strong evidence of purity because they are usually generated by the seller. Online discussion tends to blur the distinction between the approved drug and unregulated powder, which complicates interpretation of reported experiences.
PT-141 is the original development code for bremelanotide, a synthetic peptide first studied as a potential tanning and sexual-response agent in the 1990s. Researchers at a small American biotechnology firm designed it as a shortened analogue of melanotan II, which itself came from work on alpha-melanocyte-stimulating hormone. Early screening focused on pigmentation, but behavioural observations in animal models redirected attention toward sexual motivation. That shift made PT-141 one of the first melanocortin compounds investigated specifically for effects on desire rather than on skin colour.
Clinical development proceeded through two routes of administration. An intranasal formulation advanced first, but variable absorption and tolerability problems led to a switch to subcutaneous injection. The United States Food and Drug Administration approved the subcutaneous product in 2019 for hypoactive sexual desire disorder in premenopausal women. Marketing rights subsequently changed hands, and commercial availability has fluctuated since approval. Use in men, in postmenopausal women, and in combination with other agents remains outside the approved label.
Activation of MC4R in the hypothalamus is thought to influence dopaminergic signaling, which in turn affects arousal and desire. This mechanism differs from that of phosphodiesterase type 5 inhibitors, which act primarily on vascular smooth muscle in the genital region. Because the pathway is central rather than peripheral, effects are not strictly dependent on local blood flow. The precise downstream cascade linking receptor binding to behavioral outcomes remains an area of ongoing investigation.
Clinical development of bremelanotide proceeded through several reformulation attempts. An early intranasal version was discontinued, and a subcutaneous auto-injector formulation later received approval for hypoactive sexual desire disorder in premenopausal women. Approval decisions have varied by country and over time, and the product has not been universally adopted. Blood pressure elevation is a documented effect, which is why some jurisdictions require monitoring after administration. The clinical evidence base continues to evolve as additional studies are published.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H68N14O10 | Free base; the drug product is formulated as an acetate salt |
| Molar mass | About 1025 g/mol | Calculated for the free base |
| Appearance | White to off-white lyophilized powder | Typical form of research-grade material |
| CAS Registry Number | 189691-06-3 | Common listing for the free base |
| Typical storage | -20 °C, desiccated, protected from light | Repeated freeze-thaw cycles are best avoided |
Bremelanotide acts as a non-selective agonist at melanocortin receptors, with reported activity at MC1R, MC3R, MC4R and MC5R. The proposed basis for its central effects is activation of MC4R populations in the hypothalamus, a region associated with appetite and reproductive signalling. Because the peptide carries a net positive charge and polar side chains, it does not cross biological membranes freely, which is one reason oral administration is not the standard route. Effects generally appear within an hour of parenteral administration and are described as centrally mediated rather than peripheral.
Bremelanotide, developed under the code PT-141, is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone. Its structure is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, with a lactam bridge joining the aspartate and lysine side chains. The molecule has the formula C50H68N14O10 and a monoisotopic mass near 1025 daltons. It is commonly prepared as the acetate salt and appears as a white to off-white lyophilised powder in solid form. The free acid is the pharmacologically relevant species, while the counter-ion improves handling and dissolution.
The peptide contains seven amino acids arranged in a ring, closed by a lactam bridge between a side-chain acid and an amine. This cyclic constraint holds the backbone in a defined conformation and increases resistance to enzymatic breakdown relative to linear analogs. N-terminal acetylation and a C-terminal amide further protect the molecule from exopeptidases. The result is a compound with a comparatively long circulation time for a small peptide. Structural modification of the bridge alters receptor affinity, which is one reason analogs in this family differ in their subtype preferences.
Whether the behavioral effect originates centrally, peripherally, or through both remains an active question. Animal experiments using receptor antagonists and site-specific injections point toward hypothalamic melanocortin circuits as a key locus, but translating those findings to humans is not straightforward. Blood pressure changes observed in trials suggest a vascular component that may be peripherally mediated. The relationship between receptor occupancy and reported effect has not been mapped in humans, and no validated biomarker predicts response. This gap makes it difficult to explain individual variability on pharmacological grounds alone.
The AKC Standard requires 45–65 pounds (20–29 kg) and 21–23.5 inches (53–60 cm) at the shoulder for males, and 35–50 pounds (16–23 kg) and 19–21 inches (48–53 cm) for females. The UK Kennel Club Standard requires 51–56 centimetres (20–22 in) for males, and 46–51 centimetres (18–20 in) for females. Samoyed ears are thick and covered with fur, triangular in shape, and erect. They are almost always white but have a light to dark brown tint (known as "biscuit") to a greater or lesser extent. The tint is usually on the ears but can be visible on the whole body.
=== Japan === In 2006 the United States, France, and Japan signed an "arrangement" to research and develop sodium-cooled fast reactors in support of the Global Nuclear Energy Partnership. In 2007 the Japanese government selected Mitsubishi Heavy Industries as the "core company in FBR development in Japan". Shortly thereafter, Mitsubishi FBR Systems was launched to develop and eventually sell FBR technology. A 2024 technical review by Mitsubishi Heavy Industries described the revised Japanese roadmap: conceptual design and research on a demonstration sodium-cooled fast reactor were planned for fiscal 2024–2028, with a decision on basic design and licensing around fiscal 2028. MHI had been selected as the project's lead company in July 2023.
As of 2018, all human CCEEVs available are packaged as single-dose vials containing the lyophilized vaccine. They are reconstituted by adding water prior to injection. This kind of vaccines are intended to be stored at a temperature between 2°C and 8°C (36°F to 46°F): refrigerated, not frozen.
==== Provincial development ==== It can be said that Liu Wenhui's development policies were biased towards the Kham area (Kangding–Luding), as per-capita spending and credit volumes were much higher here than anywhere else in Xikang. Although Liu did comment that the Ningshu area (Xichang) was favorable towards agricultural programs, he continued prioritizing Kham. Meanwhile, population boomed in Kangding and Han agricultural settlements slowly spread throughout the province. From 1933 to 1935, some rudimentary infrastructure was constructed in his domain. This included a weapons repair shop (later expanded into a factory) and a military-political school to maintain his 24th Army. Technical schools were established for his administration and policing was strengthened. Several roads (including from Ya'an to Fulin) and canals were built or improved, hospitals and libraries were opened, and terraced farming was introduced in the rugged region. Xikang maintained an open economy encouraging private enterprise to increase trade incomes. Liu would boast of this as his "Ten Great Constructions", claiming it brought order and development to the province. For his fortieth birthday in 1935, Liu allegedly donated the money he had received from gifts to build a bridge over the Ya River. State media such as The Paper mentions the existence of a bridge built in Ya'an, but it was constructed in 1944. From 1939 on, Liu, as Governor of Xikang Province, tried to establish infrastructure to support it.
Sources: en.wikipedia.org
=== Drug product development and manufacturing === The company offers formulation development, analytical testing, solid-form screening, and clinical-stage manufacturing for oral and parenteral dosage forms. BioDuro also operates high-potency manufacturing suites for highly potent compounds and cytotoxics.
While Peyronie's disease is neither infectious nor malignant, it can have serious negative effects on sexual health and quality of life. It is diagnosed mainly on the clinical presentation supplemented by penile ultrasonography if necessary. Treatment depends on the phase and severity of the disease with conservative measures (e.g., oral therapy, traction, intralesional injection) in the milder and stable forms to surgical intervention for the advanced or stable ones. The condition is named for French surgeon François Gigot de la Peyronie, who in 1743 described the condition.
6 RCN + 4 (NSCl)3 → 6 [RCN2S2]+Cl− + 3 Cl2 + 3 N2 Sulfur trioxide successively oxidizes the compound at the sulfur atoms to (NSOCl)3. The latter is also the pyrolysis product of a mixture of phosphorus pentachloride and sulfamic acid. In principle, it exists as stereoisomers, but only one (all chlorides axial) had been isolated by 1979.
The best known was the November 4 insurrection in Cosenza, initially motivated by hunger and the housing crisis, which quickly turned into a political struggle to remove Fascist mayor Enrico Hendrich, who was ousted by popular vote. Liberation allowed anti-fascist parties to reemerge, including the Socialist Party, the Communist Party and the Christian Democracy. The latter was a Catholic-inspired organization founded in 1942 as the heir to Don Luigi Sturzo's Italian People's Party. Peasants, who made up about 60% of the population, began a series of violent uprisings demanding better conditions, including land reform. This included the return of large-scale occupations of uncultivated land. On the other side were the elite of agrarians and large landowners, who abandoned Fascism to maintain their position. In June 1944, Victor Emmanuel III handed power to his son Umberto II of Savoy, who obtained the Lieutenancy of the Kingdom. In July, a month after the liberation of Rome, Calabrian Communist Fausto Gullo, formerly minister of Agriculture in the second Badoglio government and in subsequent administrations (second Bonomi government, third Bonomi government and Parri government), proposed a series of decrees (named after him) to help the peasant class. Among them were: sharecropping reform; grants of uncultivated land to peasants in agricultural cooperatives; compensation to farmers who took their produce to storage, (previously diverted to the black market); and the prohibition of the caporale (day laborer recruiter).
The same day, Greenland's government mulled the creation of a task force with representatives from local authorities to prepare residents for potential disruptions to daily life, including guidance recommending that households keep five days of food supplies. Additionally, PM Jens-Frederik Nielsen stated that a military conflict could not be ruled out. The Joint Arctic Command announced plans to expand its military exercises, potentially conducting them on a year-round basis. A Danish defence analyst interviewed by Times Radio said Denmark discussed plans to station around 1,000 Danish ground forces in Greenland, in addition to other capabilities and allied contributions. An investigation by Times Radio suggested that it would be very hard for the US to successfully invade Greenland due to a combination of lack of US Arctic capabilities, the geography of Greenland, and Danish knowledge of the area, preparedness and Arctic training.
Sources: en.wikipedia.org
PT-141 is a research code for bremelanotide, a cyclic peptide that activates melanocortin receptors. It was developed for sexual dysfunction and later approved under a brand name as a subcutaneous injection. The same code is widely used by suppliers selling non-pharmaceutical material.
Both are synthetic melanocortin agonists and share a similar peptide backbone, but they are distinct molecules with different receptor profiles. Melanotan II was never approved as a medicine, whereas bremelanotide was. Findings about one compound should not be transferred to the other without direct evidence.
It is typically distributed as a lyophilized powder in sealed vials, sometimes with a separate solvent. Purity statements usually originate from the supplier rather than an independent laboratory. Storage recommendations vary between vendors, which makes comparison across sources difficult.
PT-141 is the research code for bremelanotide, a cyclic peptide developed as a melanocortin receptor agonist. The code has appeared in literature and catalog listings since early development. Bremelanotide is the international nonproprietary name.